» Articles » PMID: 35204013

Dynamic and Systemic Perspective in Autism Spectrum Disorders: A Change of Gaze in Research Opens to A New Landscape of Needs and Solutions

Overview
Journal Brain Sci
Publisher MDPI
Date 2022 Feb 25
PMID 35204013
Authors
Affiliations
Soon will be listed here.
Abstract

The first step for a harmonious bio-psycho-social framework in approaching autism spectrum disorders (ASD) is overcoming the conflict between the biological and the psychosocial perspective. Biological research can provide clues for a correct approach to clinical practice, assuming that it would lead to the conceptualization of a pathogenetic paradigm able to account for epidemiologic and clinical findings. The upward trajectory in ASD prevalence and the systemic involvement of other organs besides the brain suggest that the epigenetic paradigm is the most plausible one. The embryo-fetal period is the crucial window of opportunity for keeping neurodevelopment on the right tracks, suggesting that women's health in pregnancy should be a priority. Maladaptive molecular pathways beginning in utero, in particular, a vicious circle between the immune response, oxidative stress/mitochondrial dysfunction, and dysbiosis-impact neurodevelopment and brain functioning across the lifespan and are the basis for progressive multisystemic disorders that account for the substantial health loss and the increased mortality in ASD. Therefore, the biological complexity of ASD and its implications for health requires the enhancement of clinical skills on these topics, to achieve an effective multi-disciplinary healthcare model. Well-balanced training courses could be a promising starting point to make a change.

Citing Articles

Groups and Subgroups in Autism Spectrum Disorder (ASD) Considering an Advanced Integrative Model (AIM).

Ciolino A, Ferreira M, Loyacono N J Pers Med. 2024; 14(10).

PMID: 39452538 PMC: 11508306. DOI: 10.3390/jpm14101031.


Intellectually able adults with autism spectrum disorder show typical resting-state EEG activity.

Li Q, Weiland R, Konvalinka I, Mansvelder H, Andersen T, Smit D Sci Rep. 2022; 12(1):19016.

PMID: 36347938 PMC: 9643446. DOI: 10.1038/s41598-022-22597-z.

References
1.
Mussap M, Noto A, Fanos V . Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites. Expert Rev Mol Diagn. 2016; 16(8):869-81. DOI: 10.1080/14737159.2016.1202765. View

2.
Kong X, Liu J, Liu K, Koh M, Tian R, Hobbie C . Altered Autonomic Functions and Gut Microbiome in Individuals with Autism Spectrum Disorder (ASD): Implications for Assisting ASD Screening and Diagnosis. J Autism Dev Disord. 2020; 51(1):144-157. DOI: 10.1007/s10803-020-04524-1. View

3.
Waxman S . Channel, neuronal and clinical function in sodium channelopathies: from genotype to phenotype. Nat Neurosci. 2007; 10(4):405-9. DOI: 10.1038/nn1857. View

4.
Dupont C, Armant D, Brenner C . Epigenetics: definition, mechanisms and clinical perspective. Semin Reprod Med. 2009; 27(5):351-7. PMC: 2791696. DOI: 10.1055/s-0029-1237423. View

5.
Gesundheit B, Rosenzweig J, Naor D, Lerer B, Zachor D, Prochazka V . Immunological and autoimmune considerations of Autism Spectrum Disorders. J Autoimmun. 2013; 44:1-7. DOI: 10.1016/j.jaut.2013.05.005. View